• Management of recurrent or persistent non-muscle invasive bladder cancer
  View in Chinese
  • Salvage intravesical therapy
  • Risk of recurrence
  • Summary and recommendations
  • Management of NMIBC recurrence by disease state (Tables)
  • Risk factors used to define treatment of intermediate-risk NMIBC (Tables)
• Treatment of primary non-muscle invasive urothelial bladder cancer
  View in Chinese
  • Risk stratification
  • Management based on risk of recurrence
  • Summary and recommendations
  • Initial management of non-muscle invasive bladder cancer (Algorithms)
  • Bladder cancer TNM 2017 (Tables)
• Overview of the initial approach and management of urothelial bladder cancer
  View in Chinese
  • Non-muscle invasive disease
  • Differentiation
  • Summary
• Overview of the management of bladder cancer in older adults
  View in Chinese
  • Medically fit patients > Non-muscle invasive bladder cancer
  • Medically frail patients > Non-muscle invasive bladder cancer
  • Summary and recommendations
• Clinical presentation, diagnosis, and staging of bladder cancer
  View in Chinese
  • Summary
• Patient education: Bladder cancer treatment; non-muscle invasive (superficial) cancer (Beyond the Basics)
• Infectious complications of intravesical BCG immunotherapy
  View in Chinese
  • Prevention
  • Summary
• Epidemiology and risk factors of urothelial (transitional cell) carcinoma of the bladder
  View in Chinese
  • Cigarette smoke
  • Summary
• Radical cystectomy and bladder-sparing treatments for urothelial bladder cancer
  • Non-muscle invasive bladder cancer
  • Summary and recommendations
• Principles of cancer immunotherapy
  View in Chinese
  • Cytokines
  • Summary
• Chemoprevention of urothelial carcinoma of the bladder
  View in Chinese
  • Retinoids
  • Nonsteroidal antiinflammatory drugs
  • Summary
• Pathology of bladder neoplasms
  View in Chinese
  • Summary
• Bladder preservation treatment options for muscle-invasive urothelial bladder cancer
  • General approach
  • Summary and recommendations
• Urine biomarkers for the detection of urothelial (transitional cell) carcinoma of the bladder
  View in Chinese
  • Microsatellite analysis
  • Nuclear matrix protein 22
  • Summary
• Screening for bladder cancer
  View in Chinese
  • Summary and recommendations
• Malignancies of the renal pelvis and ureter
  View in Chinese
  • Posttreatment surveillance
  • Summary and recommendations
• Laparoscopic/robotic-assisted radical cystectomy
  View in Chinese
  • Summary and recommendations
• Cystitis in patients with cancer
  View in Chinese
  • Summary
• BCG vaccination
  • Summary and recommendations
• Patient education: Bladder cancer treatment; invasive cancer (Beyond the Basics)

Topic Outline Hide Topic Outline Show Graphics (0)